AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services appropriations and asked for additional FDA funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center, funding for specialized pharmacy resident programs, and direct reimbursement under the Medicare program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.